Copper(II) complexes of methimazole, an anti Grave's disease drug. Synthesis, characterization and its potential biological behavior as alkaline phosphatase inhibitor

BioMetals

Volumn 23, Issue 2, 2010, Pages 255-264

  Urquiza, Nora M ^a   Manca, Silvia G ^a   Moyano, María A ^a   Dellmans, Raquel Arrieta ^a   Lezama, Luis ^b   Rojo, Teófilo ^b   Naso, Luciana G ^c   Williams, Patricia A M ^c   Ferrer, Evelina G ^c  

^a UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

ALP inhibition; Biometals; Copper; EPR; FTIR; Grave's disease; Methimazole; UV visible

Indexed keywords

ALKALINE PHOSPHATASE; COPPER COMPLEX; METHIMAZOLE COPPER COMPLEX; THIAMAZOLE; UNCLASSIFIED DRUG; ANTITHYROID AGENT; COPPER;

ARTICLE; CONTROLLED STUDY; DIFFUSE REFLECTANCE SPECTROSCOPY; DISSOLUTION; DRUG STABILITY; DRUG SYNTHESIS; ELECTRON SPIN RESONANCE; ENZYME INHIBITION; INFRARED SPECTROSCOPY; THERMOGRAVIMETRY; ULTRAVIOLET SPECTROPHOTOMETRY; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; GRAVES DISEASE; HUMAN; METABOLISM; SYNTHESIS;

ALKALINE PHOSPHATASE; ANIMALS; ANTITHYROID AGENTS; COPPER; ELECTRON SPIN RESONANCE SPECTROSCOPY; GRAVES DISEASE; HUMANS; METHIMAZOLE; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 77952538874     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10534-009-9283-7     Document Type: Article

References (50)

1. Abdou H (1989) Dissolution, bioavailability & bioequivalence. Mack Printing Company, Easton, pp 481-490
2. Ainscough EW, Bingham AG, Brodie AM (1987) The interactions of thiol with copper (II): an electron spin rsonance study. Inorg Chim Acta 138:175-177
3. Ainscough EW, Baker EN, Bingham AG, Brodie AM (1989) The interaction of 1-methylimidazoline-2(3H)-thione with copper (II) salts. J Chem Dalton Trans 1:39-42
4. Al Moutaery A (2003) Methimazole prevents stress and chemical induced gastropathy in rats. Experim Toxicol Pathol 55:277-285
5. Bacic-Vrca, Skreb F, Cepelak I, Mayer L, Kusic Z, Petres B (2005) The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease. Clin Chem Lab Med 43:383-388
6. Bakhtiar R, Ochiai EI (1999) Pharmacological applications of inorganic complexes. Gen Pharmacol 32:525-540 (Pubitemid 29219454)
7. Battaglia LP, Bonamartini Corradi A, Nardelli M, Vidoni Tani ME (1976) X-ray crystal structures of tetrakis(imidazoline- 2-thionate)copper(I) nitrate and dichloro-l-imidazoline- thionato-tris(imidazoline-2-thionato)dicopper(I). J Chem Dalton Trans 2:143-146
8. Bell NA, Clegg W, Coles SJ, Constable CP, Harrington RW, Hursthouse MB, Light ME, Raper ES, Sammon C, Walker MR (2004) Complexes of heterocyclic thiones and group 12 metals: part VI. Preparation and characterisation of complexes of cadmium(II) halides with 1-methylimidazoline- 2(3H)-thione, 1, 3-thiazolidine-2-thione and 1, 3- benzothiazoline-2-thione.Crystal structures of polymeric (1, 3-thiazolidine-2-thione)cadmium(II) chloride, bis(1, 3- thiazolidine-2-thione)cadmium(II) iodide and monomeric bis(1-methylimidazoline- 2(3H)-thione)cadmium(II) bromide. Inorg Chim Acta 357:2091-2099
9. Belle C, Rammal W, Pierre JL (2005) Review article: sulfur ligation in copper enzymes and models. J Inorg Biochem 99:1929-1936
10. Bertini I, Luchinat C (1983) An insight on the active site of zinc enzymes through metal substitution. In: Sigel H (ed) Metal ions in biological systems, vol 15. M. Dekker, New York, p 101
11. Buncel E, Norris AR, Taylor SE, Racz WJ (1982) Metal ionbiomolecule interactions. IV. Methylmercury(II) complexes of 1-methylimidazoline-2-thione (methimazole), a potentially useful protective agent in organomercurial intoxication. Can J Chem 60:3033-3038
12. Cameron BR (2001) Baird IR, metals in medicine: a review of the symposium. J Inorg Biochem 83:233-236
13. Chandra SL, Gupta K (2005) EPR, mass, IR, electronic, and magnetic studies on copper(II) complexes of semicarbazones and thiosemicarbazones. Spectrochim Acta part A 61:269-275
14. Chih-Tsueng H, An-Tsz H, Dee P, Yi-Jen H, Ling-Yi W, Tsao- Chin Y, Wei-Cheng L, Wen-Sheng H, Shi-Wen K (2004) Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. Clin Endocrinol 60:676-681
15. Cortizo AM, Sálice VC, Etcheverry SB (1994) Vanadium compounds. Their action on alkaline phosphatase activity. Biol Trace Element Res 41:331-339
16. Diplock AT (1991) Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr 53:189S-191S
17. Etcheverry SB, Cortizo M (1998) Vanadium bioactivity on cells. In: Tracey AS and Crans DC (Eds) Vanadium compounds (chemistry, biochemistry and therapeutic applications), chapter 21, Am Chem Society, pp 270-276
18. Etcheverry SB, Barrio DA, Williams PAM, Baran EJ (2001) On the interaction of the vanadyl(IV) cation with lactose. Biol Trace Element Res 84:227-238
19. Etcheverry SB, Ferrer EG, Naso L, Rivadeneira J, Salinas MV, Williams PAM (2008) Antioxidant effects of the VO(IV) Hesperidin complex and its role in cancer chemoprevention. J Biol Inorg Chem 13:435-447
20. Ferrer EG, Salinas MV, Correa MJ, Vrdoljak F, Williams PAM (2005) ALP inhibitors: vanadyl(IV) complexes of ferulic and cinnamic acid. Z Naturforsch 60b:305-311
21. Ferrer EG, Salinas MV, Correa MJ, Naso L, Barrio DL, Etcheverry SB, Lezama L, Rojo T, Williams PAM (2006) Synthesis, characterization, antitumoral and osteogenic activities of quercetin vanadyl(IV) complexes. J Biol Inorg Chem 11:791-801
22. Guillon E, Déchamps-Olivier I, Barbier JP (1998) Structural characterization by ESR of copper complexes with unsymmetrical S\O or S\N bidentate thiourea derivative ligands. Polyhedron 17:3261-3265
23. Hathaway BJ, Billing DE (1970) The electronic properties and stereochemistry of mono-nuclear complexes of the copper( II) ion. Coord Chem Rev 5:143-207
24. Huang Q, Shindo H (2000) Effects of copper on the activity and kinetics of free and immobilized acid phosphatase. Soil Biol Biochem 32:1885-1892
25. Jolley J, Cross WI, Pritchard RG, McAuliffe CA, Nolan KB (2000) Synthesis and characterization of mercaptoimidazole, mercaptopyrimidine complexes of platinun(II) and platinun(III).The crystal and molecular structures of tetra(2-mercaptobenzimidazole)- and tetra(2-mercaptoimidazole) platinun(II)choride. Inorg Chim Acta 315:36-43
26. Kasraee B, Hügin A, Tran C, Sorg O, Saurat JH (2004) Methimazole is an inhibitor of melanin synthesis in cultured B16 melanocytes. J Investig Dermatol 122:1338-1341
27. Kocjan T, Wraber B, Kocijancic A, Hojker S (2004) Methimazole without improving the existing Th1/Th2 imbalance in Graves' disease. J Endocrinol Investig 27:302-307
28. Lever ABP (1984) Inorganic electronic spectroscopy, 2nd edn. Elsevier, The Netherlands Li M, Ding W, Baruah B, Crans DC, Wang R (2008) Inhibition of protein tyrosine phosphatase 1B and alkaline phosphatase by bis(maltolato) oxovanadium (IV). J Inorg Biochem 102:1846-1853
29. Martin CJ, Evans WJ (1991) Reversible inhibition of intestinal alkaline phosphatase by inositol hexaphosphate and its Cu(II) coordinate complexes. J Inorg Biochem 15:177-178
30. Mcmillin DR, Morris MC (1981) Further perspectives on the charge transfer transitions of blue copper proteins and the ligand moieties in stellacyanin. Proc Natl Acad Sci USA 78:6567-6570
31. Nakamoto K (1986) Infrared and Raman spectra of inorganic and coordination compounds. Wiley, New York
32. Naso LG, González Baró AC, Lezama L, Rojo T, Williams PAM, Ferrer EG (2009) Synthesis, chemical speciation and SOD mimic assays of tricarballylic acid-copper(II) and imidazole-tricarballylic acid-copper(II) complexes. J Inorg Biochem 103:219-226
33. Peters KG, Davis MG, Howard BW, Pokross M, Rastogi V, Diven C, Greis KD, Eby-Wilkens E, Maier M, Evdokimov A, Soper S, Genbauffe F (2003) Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium); unliganded vanadium (VO4) as the active component. J Inorg Biochem 96:321-330
34. Pettinari C, Pettinari R, Pellei M, Lobbia GG (1999) Synthesis and characterization of derivatives of copper(I) with Nand S-donor ligands V. Imidazole and imidazoline-2(3H)- thione derivatives. Polyhedron 18:1941-1951
35. Proc. NatL Acad. Sci. USA 78: 6567-6570
36. Raper ES (1996) Complexes of heterocyclic thionates. Part 1. Complexes of monodentate and chelating ligands. Coord Chem Rev 153:199-255
37. Raper ES (1997) Complexes of heterocyclic thionates, Part 2: complexes of bridging ligands. Coord Chem Rev 165: 475-567
38. Raper ES, Brooks JL (1997) Complexes of 1-methylimidazoline- 2-thione with Co(II) and Zn(II) halides and perchlorates. J Inorg Nucl Chem 39:2163-2166
39. Raper ES, Creighton JR, Clegg W (1991) Tetrahedro-[Tetrakis {(1-methylimidazoline-2(3H)-thionato) copper(I)}]: electrochemical synthesis, thermal analysis, cyclic voltametry and crystal atructure. Inorg Chim Acta 183:179-187
40. Raper ES, Creighton JR, Bell NA, Clegg W, Cucuruil-Sfinchez L (1998) Complexes of heterocyclic thiones and group twelve metals. Part 1. Preparation and characterisation of 1:1 complexes of mercury (II) halides with 1-methylimidazoline- 2(3H)-thione: the crystal structure of [(l2-dibromo) bis (trans (bromo) (1 -methyl-imidazoline-2 (3 H) -thione) mercury (II))] at 160 K. lnorg Chim Acta 277:14-20
41. Redher D (2003) Biological and medicinal aspects of vanadium. Inorg. Chem Comm 6:604-617
42. Renella G, Ortigoza ALR, Landia L, Nannipieri P (2003) Additive effects of copper and zinc on cadmium toxicity on phosphatase activities and ATP content of soil as estimated by the ecological dose (ED50). Soil Biol Biochem 35:1203-1210
43. Rueter JG (1983) Alkaline phosphatase inhibition by copper: Implications to phosphorus nutritiion and use as a biochemical marker toxicity. Limnol Oceanogr 28:743-748
44. Taylor DM, Williams DR (eds) (1995) Trace element. Medicine and chelation therapy. Royal Society of Chemistry, Candbridge
45. Tene C, Zárate A, Basurto L, Islas S, Revilla C, Ochoa R, Galván RP (2001) Correction of insulin resistence in methimazole-treated patients with Grave's disease. Rev Invest Clin 53:531-535
46. Thompson KH, McNeill JH, Orvig C (1999) Vanadium Compounds as Insulin Mimics. Chem Rev 99:2561-2571
47. U.S. Pharmacopeia National Formulary; USP30/NF, 2007, US pharmacopeial convention, Rockville, MD
48. Whyte MP (2007) Hypophosphatasia chapter 207, Part 22: connective tissue. In: Valle D, Beaudet A,Vogelstein B, Kinzler K, Antonarakis S, Ballabio A, Scriver C, Sly WS, Childs (eds). BOMMBID-The online metabolic and molecular bases of inherited disease. Mc Graw Hill, pp 1-41
49. Williams DR (1972) Metals, ligands, and cancer. Chem Rev 72:203-213
50. WINEPR SimFonia (1996) v1.25, Bruker Analytische Messtecnik GmbH